teine-rich domains in the extracellular (amino-terminal) domain, which have been shown to be involved in ligand bindextracellular region between the human family members are in the range of 25% to 30%.5,26 The NGFR, TNFR-I, TNFR-11, and FAS/APO-1 have a broad tissue distribution, whereas the others (CD27, CD30, CD40, 4-1BB, and 0x40) are mainly restricted to cells of the lymphoidhematopoietic sysLigands for these receptors have been identified and belong to two recently formed cytokine superfamilies. The neurotrophins (NT; NGF ligand superfamily) are basic, NGF-like dimeric soluble molecules and include NGF, BDNF, NT-3, NT-4, and NT-5.27,28 The ligands of the TNF ligand superfamily are acidic, TNF-like molecules with approximately 20% sequence homology in the extracellular domains (range, 12% to 36%) and exist mainly as membrane-bound forms; the biologically active form is a trimeric/ multimeric complex. To this group belong TNF,29-32 LTcx,"~.~~ LTP,3s CD27L,36 CD30L,37 CD40L:842 4-1BBL,'",44 0X40L,45,46 and FASL.47-50 Soluble forms of the TNF ligand superfamily have only been identified so far for TNF, LTcx, of cell proliferation, activation, and differentiation, including control of cell survival or death by apoptosis or cytotoxicit^.^,'
Malignant lymphomas are a heterogenous group of lymphoid tumors that mainly arise from the lymphoreticular system and are grouped, based on morphologic criteria, into two large categories, Hodgkin's disease (HD) and nonHodgkin lymphomas (NHL).53 Furthermore, lymphomas are grouped into three major phenotype categories: B cell, T cell, and HD. The origin of the lymphoma cells in NHLs is most commonly from B cells (90%) and less frequently from T cells (lo%), with massive clonal expansion of the malignant cell population. In contrast, HD is defined by common clinical and pathologic
The diagnosis of HD is typically based on a disrupted lymph node architecture and the presence of the malignant mononucleated Hodgkin and multinucleated Reed-Stemberg (H-RS) cells embedded in an abundance of normal, reactive cells (eg, lymphocytes, histiocytes, eosinophils, plasma cells, and stromal cells) without malignant tran~formation.'~ HD contains only a low proportion of the neoplastic H-RS cells, accounting for usually less than 1% to 2% of the total tumor cell m a~s .~~. " -~" The etiology of HD and the origin of the H-RS cells remains unclear with almost every cell type having been described as a normal ~ounterpart. For personal use only. on July 15, 2017. by guest www.bloodjournal.org From role and pathobiologic involvement of the TNF/NGF receptor and TNF ligand superfamilies for the pathology of malignant lymphomas.
STRUCTURAL FEATURES OF TNF RECEPTOR AND LIGAND SUPERFAMILIES
The TNF receptor superfamily consists, at present, of 10 mammalian In addition, several viral open reading frames (ORFs) have been identified that encode acquired soluble TNF receptors (eg, SFV-T2, va53, SaIF 19R, MYX-T2, G4R, and crmB).10*20-22.66-70 The TNF ligand superfamily contains nine members, ie, the counterparts of the receptors.* The ligand for the low-affinity NFG receptor is structurally unrelated to the TNF superfamily of ligand^.'^ The crystal structures of TNFRI (p60), TNF, and LTa have been s01ved~"~~ and the mechanism of receptor-ligand interaction was i l l~s t r a t e d .~~.~~ The ligand is a trir~~er.~'.~' The receptor extracellular ligand binding region is a rod-like structure in which the four cysteine-rich 40 residue repeats each folds tightly together and forms intimate longitudinal contacts with its neighbors. The complex contains one LTaI TNF homotrimer and three receptor chains. 73 The receptors bind in three grooves in the ligand trimer formed by the subunit interfaces; thus each receptor makes contact with two subunits. The structure predicts that the binding of ligand will crosslink three receptors together into a cluster. Recent reports suggest that, for LTa, this model may be an oversimplification. A second form of lymphotoxin (lymphotoxin-P [LTP] or p33) has been identified35.75.76 that unlike LTa, appears to be membrane anchored. The TNFR-related protein (TNFRF') has been shown to be a specific receptor for LTP and hence is TNFRIII.77 In addition, it appears that LTa and LTP, when expressed in the same cell, can form heterotrimeric complexes.76 Because the sites for receptor binding lie at the subunit interfaces, such heterotrimers can contain three different sites (a2, P2, and ap) in various combinations depending on subunit stiochiometry. In which way such heterotrimeric ligands interact with cells expressing combinations of TNFRI, TNFRII, and TNFRIII needs to be clarified.
The overall structures of two TNFR-like viral gene products, the TNF receptors and the ligands, are shown in Fig   1. In addition, Tables 1 and 2 summarize the sizes of the proteins as lengths of the various sequence segments and chromosomal location. Sequence alignments of the extracellular regions of the receptors show that they are distantly related (25% to 30% in general; summarized in Table 3 ). However when sequence conservation patterns are examined, two features are immediately apparent?." First, there is a characteristic pattern present in all the sequences, with the majority of conserved positions containing an unusually large number of cysteine residues. Second, all of the proteins are composed of several repeats of a core domain of 30 to 40 residue^.^.'^.^' The TNFRI crystal structure shows that this domain is composed of three elongated strands of residues held together by a twisted ladder of three disulphide bonds73; the strands that form the core of the structure contain approximately 25 residues, of which 6 are cysteines. The strands are joined by loops of less-conserved structure. Thus, the three-dimensional structure shows that the cysteine-rich repeats in the sequence present the charcteristic structural domain in this family. TNFRI contains four such domains stacked longitudinally to form a bent rod. This rod structure thus forms an extended ligand binding unit, with the ligand contact side chains being located in domains 2 and 3. The largest variation in structure between the family members is found in the region between the C-terminus of the membrane proximal domain and the transmembrane region. This segment varies from 8 residues in FASI8 to 70 residues in CD27I3 and is presumed to form a variable spacer between the ligand binding unit and the membrane. CD30 has an extracellular region in which the cysteine-rich repeat unit has been d~p1icated.l~ The observation that the CD30a and CD30b regions are far more closely related (50%; see Table  3 ) than any of the other family members are, suggests that this structure has arisen from tandem duplication event more recent than those that gave rise to the various family members from a common ancestor. CD30a is as related to the rest of the family as any of the other members, but CD30b, the membrane proximal region, is the most divergent sequence of the family (Table 3) . It seems likely therefore that it has evolved rapidly away from the rest of the family, may well have lost ligand binding activity, and serves the purpose of an extended spacer.
It is striking that this family of molecules shows a relatively low level of sequence conservation despite in all likelihood sharing a common fundamental structure. This finding suggests that the sequences have diverged rapidly. In support of this notion, comparisons of the sequences of the same member from different species show unusually low levels of conservation. This finding can be seen from two examples included in Table 3 , ie, OX40 and CD40. In both cases the human and murine forms are only approximately 60% identical. For example, by contrast, the murine and human insulin receptor precursors are 95% identical when comparing the entire 1370 residues sequences. The selection pressure driving rapid divergence of the TNF receptor family members may well arise from the subversion of these systems by pathogens. Thus, a number of TNFR viral ORFs (SFV-T2, va53, SaIF 19R, MYX-T2, G4R, and crmB) have been detected by sequence homology and found to be soluble TNF binding proteins capable of blocking TNF action.20.22369
These viral genes were presumably acquired from a host species by recombination and confer a selective advantage for the viruses by attenuating host immune and inflammatory responses. As a corollary of this argument, one would expect that evolution of a mutated ligand-receptor pair that was no longer inhibited by the viral gene product would be advantageous to the host.
Comparison of the cytoplasmic sequences of the receptors shows these to be considerably more diverse than the extracellular regions. Indeed, these differ markedly not only in sequence but also in size (Tables 2 and 3) , and multiple sequence alignments show no evidence of any underlying shared structure running through the family. One striking comparison is that between murine and human CD40; whereas the membrane proximal 34 residues are 78% identical, the murine molecule possesses an additional 27 residues For personal use only. on July 15, 2017. by guest www.bloodjournal.org From LT is shown in both the homotrimeric, secreted LTrr form and the heterotrimeric, membrane-anchored LTqLTp complex. Pro-TNF and FASL can be proteolytically cleaved for the release of active soluble forms. NGF is a basic, soluble dimeric molecule and the prototype of the NGF ligand superfamily. NGF has no homology to the TNF ligands and is therefore not included.
at the C-terminus. There are some elements shared between subsets of family members, thus TNFRI and FAS share the so-called "death d~main",~"'" but this sequence element is missing in the other two TNF receptors (TNFRII and TNFRPITNFRIII).'".'~.~~ Whether this degree of diversity is the consequence of rapid accumulations of mutations in this region of the genes for these molecules or of recombination events is not clear. However, it seems reasonable to suppose that there is unlikely to be any common immediate-early signalling event triggered through all these receptors. Indeed comparison of the sequences of this group of molecules as a whole with the databases fails to identify any motifs that resemble other families of signalling molecules, thus offering no clues as to what the immediate early events for any of these molecules might be. Relatively little general information is yet available about the signal pathways to which the more recently characterized family members (CD40, CD30, 4-1BB, CD27, 0x40, and FAS) might couple, but a diverse set of signalling pathways seems likely for the divergent biologic responses. Most data for signalling through TNF receptors have come from studies using the TNFRI (p60) and TNFRII (p80) system and have been reviewed in detail recently."
The extracellular regions of TNF ligand family, like the receptors, are highly diverse in sequence, with identity levels in the region of 20% for different family members. The murine and human forms of the same molecule are somewhat more conserved than the corresponding receptors, being approximately 80% identical (Table 3C) . However, sequence alignments show that as with the receptors there is a characteristic pattern of sequence conservation, there being 9 short regions of conserved sequence distributed along the length of the molecules (Fig 2) . Superposition of the sequences on the three-dimensional structures of TNF and LTa shows that these regions correspond to the strands that form the core of the protein. The residues that lie on the loops joining the strands show no detectable conservation. Thus the ligand family has diverged as rapidly as the receptors. Several of the ligand superfamily members have moderate sized cytoplasmic regions, and at least some are capable, when engaged by their receptors, of delivering signals (eg, CD27L, CD40L, and 4-1BBL)."" The signal pathway is presently unknown. shock, some autoimmune disorders, malignancies, and graftversus-host disease.' The nine TNF-related cytokines show distinctive but overlapping cellular responses for developmental and regulatory networks involving cells of the lymphoid, hematopoietic, and other lineages, such as stromal cells and neuronal cells.4,' At least some of the nine TNF ligand superfamily members (eg, TNF, LTa, LTP, and CD40L) form trimeric proteins members exert their biologic activity by causing receptor multimerization at the cell surface.73 As mentioned above, the LT0 homotrimer is the only entirely secreted protein and the TNF homotrimer is active after proteolytic release form the cell s~r f a c e .~~, '~.~~
The biologically relevant forms of the other family members are membrane-bound type I1 glyco-CD30L, CD40L, 4-lBBL, and OX40L have not been reported. The exception is FASL, which exists in the predicted membrane-bound form but also as a soluble shed form in COS cell supernatants with presently unknown biologic relevance."
Most of the TNF receptor superfamily members exist also in a soluble form, released by proteolytic cleveage (eg, TNFR p60, TNFRp80, CD27, CD30, CD40, and FAS) or through alternative splicing (eg, 4-1BB Natural soluble forms for CD27L, between two or more ligands.' Biologic activities related to T-cell-mediated immunity are a unique feature for all members of the TNF ligand All ligands and receptors, without exception, are expressed on activated T cells (Table 4) . Purified human T cells and Tcell clones show enhanced proliferation when stimulated with any recombinant TNF family ligand or crosslinked with antireceptor antibodies in the presence of anti-CD3 or other mitogens, such as phytohemagglutinin (PHA), phorbol myristate acetate (PMA), or Possible autocrine T-cell activation and growth control might be a common feature of this protein family. The induction of each ligand expression shows unique kinetics consistent with different roles for each of these ligands in the T-cell activation."' For example, the induction of CD30L surface expression on activated T cells is slower in comparison to other TNF ligands such as TNF, CD27L, CD40L, and 4-1BBL (maximal expression, 24 hours v 6 hours, respectively). Bcell proliferation and Ig secretion is induced by at least TNF, LTa, and CD40L. Further, several members participate in Tcell-dependent help for B cells, which are known to express TNFR-I, TNFR-11, CD27, CD30, CD40, FAS, and 4-1BB (Table 4) .'06,'07 TNF, LTa, and CD4OL are mitogenic to B ce~~s~38.108-ii0 TNF, CD30L, and 4-1BBL are also abundantly expressed by activated macrophage^.^^,^^.^^^'^ Signals generated by TNF superfamily ligands in target cells are productively coordinated with accessory molecule expression (eg, LFA-1, ICAM-1, and B7
For example, TNF, LTa, CD30L, and CD40L are capable of inducing cellular aggregation and upregulation of LFA-1 (CD 1 la)/ICAM-1 Receptors  CD27  175  21  46  2.5  CD30  360  27  21 1  5.5  CD40  175  21  62  4  FAS  156  20  144  3  OX40  188  26  36  3.5  TNFRl  190  25  220   4   TNFRll  240  27  173  4  TNFRlll  20 1  26  187  4  4-1 BB  159  30  45  3.5  NGFR  225  23  154  4  Ligands  CD27L  165  16  12  CD30L  172  26  36  CD40L  216  23  22  LTa  170  24  11  LT4  197  31  16  OX40L  139  21  23  TNF  176  28  29  4-1BBL  206  21  82  FASL  179  27  75 With the exception of 4-168 and 4-1BBL. all sequences used in the analysis were those of human proteins.
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From The sequences were compared in individual pairs using BESTFIT. For the receptors, the regions compared were those defined in Table 1 . For the ligands, the regions compared were the entire region C-terminal to the membrane spanning sequence. The values given are percent amino acid identity, allowing gaps to be placed to optimize the fit. The extracellular region of CD30 contains the same concensus sequences as the other receptors, but has been duplicated (see Fig 1) to be able to compare it directly with the other members; each of the duplicated regions was treated separately. CD30a is residues 23-190 of CD30 (numbered from the initiator Met) and CD3Ob is 191-379.
Abbreviations: Hu, human; Mu, murine; TRII, TNFR II (~8 0 ) ; TRI, TNFR l (p60); TR-RP, TNFR-RP (related protein).
(CD54) e~pression."""~ CD30L and CD40L share the ability to induce B7-1 and B7-2 expression, part of the strongest known T-cell costimulatory pathway.""'z0 In general, all TNF ligand superfamily members, including FASL and CD40L, are essential for T-cell costimulation and activation. It is of special interest that signals, at least through CD27L, CD40L, and 4-1BBL, can provide costimulation for activated peripheral blood (PB) T cell^.*^^*^ Further studies need to be performed to see if other TNF ligand superfamily members are able to transduce a costimulatory signal. The ability to induce cell death (necrosis andor apoptosis) is another unique feature of this family and is presently established for TNF, LTa, CD30L, 4-1BBL, and broadly on both myeloid, lymphoid, and stromal FAS mmoclonal antibodies (MoAbs) and FASL induce apoptotic (programmed) cell death and FASFASL interaction appears to be involved in T-cell repertoire formation, including positive or negative selection, suggesting a role of the FAS-FASL interaction in peripheral T-cell tolerance."3126136 Interestingly, the cytoplasmic domains of the 60-kD TNFR and the FAS antigen contains a 65 amino acid "death domain," which is critical for signal transduction of the cytotoxic effect~.7~.'~~ Both receptors still use at least partially distinct s i e g path- 
CD27L AND CD70 ARE IDENTICAL MOLECULES AND ARE EXPRESSED ON DIFFERENT LYMPHOMAS
The CD70 antigen was originally identified by the Ki-24 MoAb.I6' CD70 is expressed on many peripheral T-and Bcell lymphomas (50% to 70% of cases positive) with frequent CD70 positivity observed within the cytoplasm.'62 The strongest expression is found on H-RS cells of HD (96% to 100% of cases positive) followed by large-cell NHLs (60% to 80% of cases positive). CD70 expression was not found on lymphoma cells derived from precursor T and B cells, such as lymphoblastic lymphoma or acute lymphoblastic leukemia (ALL). Permanent cell lines showed high CD70 expression only in those cell lines related to activated cells (eg, antigens, mitogens, and viral-transformed cells), but not in those resembling precursor T or B cells. In most cases, expression of the CD70 molecule is associated with the expression of other activation antigens, particularly CD25 and CD30.I6* However, 20% of B-cell NHLs and 5% of T-cell NHLs expressed only CD70 antigen on the lymphoma cells. '62 For the immune system, CD70 is absent from resting lymphocytes, but can be induced after activation.'" CD70 antigen is detectable on PHA-stimulated T and B lymphocytes after 24 hours and peaked at 96 hours, with 70% of stimulated peripheral blood B cells and 25% of T cells expressing the antigen.I6' CD70 expression could not be detected on resting or IFN-y-treated monocytes, neutrophils, or dendritic cells. Recently, the CD70 gene was cloned and found to be identical to the cloned ligand for CD27 (CD27L).36.83*90 CD27 is expressed by medullary thymocytes, most peripheral blood T cells, a subset of mature B cells, and NK The biologic functions of CD27L include a costimulatory signal for T-cell proliferation, generation of cytotoxic T cells, and enhanced cytokine secretion,36 but its functional relevance for thymocytes and B cells remains to be elucidated. It is of interest that only CD27+ B cells can be induced to secrete Ig in vitro after stimulation with mitogens or CD27L.164.'65*'72 In addition, CD27L antibodies or C D 2 7 block allogenic B-cell-mediated stimulation of T-cell prolif-CD27LJCD70 molecule is expressed on most lymphocytes in occassional tonsil germinal centers, low number of lymphocytes in the paracortical areas of tonsils, lymphoblasts in the skin and gut, and thymic epithelial cells, but not on cortical and medullary thymocyte^.'^^,'^' Preliminary functional data suggest that the CD27-CD27UCD70 interaction is part of the network involved in regulation of T-cell activation during antigen-specific immune responses, generation of memory T-cell populations, and expansion of cytotoxic T cells.'74
A relatively high percentage of T-and B-cell NHLs but also HD express CD27UCD70; this expression is characteristically high on H-RS cell^.'^^.'^^ In addition, most HDderived cell lines express CD27L surface molecules but not the counterstructure CD2763 (H.J.G., unpublished observation). B-cell NHL cell lines can express both the CD27 and CD27LKD70 molecule, but its functional relevance for the growth control of these cells has not been established. CD27 expression was found in 50% of B-cell leukemias and 71% of B-cell CD27 was present on malignant B cells corresponding to early stages of antigen-independent B-cell maturation. Pro-B-cell ALLs were CD27-, but 30% of pre-B-cell ALLs were positive. Mature B-cell ALLs had a high level of expression of CD27 and chronic lymphocytic leukemia (CLL), prolymphocytic leukemias, and some hairy cell leukemias (HCL) were moderate to strong CD27+. In addi- tion, most low-grade diffuse and follicular lymphomas (85% of cases positive) and intermediate-and high-grade lymphomas (62% of cases positive with variable expression levels) expressed CD27 on the malignant B-cell population. Myeloma cells lacked expression of CD27. Furthermore, sCD27 was elevated in the serum of patients with B-cell malignancies and the highest levels were observed in patients with CLL and low-grade NHLs. The sCD27 serum levels showed a strong correlation to the tumor load, indicating sCD27 s e m levels as a useful disease marker in patients with Bcell malignan~ies.'~~ Taken together, CD27 and CD27UCD70 seem to be expressed with high frequency by the malignant cells of different entities of lymphomas and may serve as markers for tumor burden and disease activity, but any functional correlation to defined pathophysiologic presentation has not been established (Fig 3) .
CD30 AN HD-ASSOCIATED ANTIGEN AND ITS LIGAND
HD-derived cell lines were used to develop MoAbs that could be used to visualize H-RS cells in tissue sections. Ki-1, the first CD30 MoAb, was raised against the HD-derived cell line L-428 and described to react uniquely with primary and cultured H-RS cells.'" A small lymphoid cell population in reactive tonsils was also stained and postulated to be the precursor cells for H-RS cells.'78 Subsequent studies clearly showed that the CD30 MoAb (Ki-l) was neither cell-lineage restricted nor specific for H-RS cells.'79 Over the years, multiple MoAbs against the CD30 antigen (eg, Ber-H2, HeFi, HRS-l, HRS-2, HRS-3, M44, M67, and C10) have been generated with better immunochemical properties than Ki-CD30 MoAbs detect a phosphorylated 120-kD membrane glycoprotein and its nonphosphorylated 84-kD precursor protein.'",'8s The cloning of the CD30 antigen has suggested that it might act as a cyt~kine.receptor.'~~'~ In addition to the CD30 staining for a small cell population in the parafollicular area of hyperplastic lymph nodes and tonsils, most blasts appearing during infectious mononucleosis are positive for CD30 expre~sion.'~~~'~'~'~~.'~~ CD30 expression has also been detected on a subset of mitogenor antigen-activated PBTs, Epstein-barr virus (EBV)- 
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Activation of lymphoid cells The analysis of 105 continous human leukemia-lymphoma cell lines for CD30L showed a restricted expression pattern for 6 of the 26 B-cell-lineage tumor cell lines (4 CD30-Burkitt lymphoma [BL] cell lines, 1 CD30-BL-like ALL, and 1 NHL).222 All HD-derived cell lines were CD30L mRNA and surface protein expression negative.I2' Recombinant CD30L was mitogenic for the "T-cell-like" HD-derived cell lines HDLM-2 and L-540 and the T-ALL cell line KE-37 but not for the "B-cell-like'' HD-derived cell lines KM-H2 and L-428 or CD30+ BL cell lines.I2' In addition CD30L is capable of enhancing IL-6, TNF, and LTa secretion for HD-derived cell lines and upregulates surface expression of ICAM-1 and B7 family members in a similar fashion as seen for CD40L (see below).Il7 CD30L seems to be another paracrine-acting molecule involved in the deregulated cytokine and activation cascade, characteristic for HD.64 CD30L could be produced by H-RS cell surrounding bystander cells, such as activated CD4+ T cells and activated macrophages and granulocytes (Fig 4) . CD30L could modify cytokine secretion of H-RS cells and enhance proliferation and activation of H-RS cells, including upregulation of cell contact-dependent signals. The overexpression of the cytokine receptor CD30 on most H-RS cells appears to be an important clinical, biologic, and pathologic marker for HD (Fig 4) . Further understanding of the CD30-CD30L interaction for the oncogenesis of HD will be hopefully generated from studies analyzing CD30L expression in primary HD cases and in vivo models, such as the HD-SCID mice system.
CD3OL TRANSDUCES ANTIPROLIFERATIVE SIGNALS TO CD30+ ALCLs
CD30' ALCLs (approximately 10% of all NHLs) express characteristically high amounts of CD30 on the surface of their clustered malignant lymphoma cells with either T, B, or 0 phenotype.I7* CD30+ ALCLs are characterized by the presence of large, pleomorphic tumor cells; expression of lymphocyte activation antigens (eg, CD25, CD30, CD71, and MHC class 11); a frequent nonrandom chromosomal abnormality (t:2; 5); and frequent extranodal disease affecting the skin, lung, gastrointestinal tract, soft tissue, and CD30' ALCL can be confused with HD because of the presence of occasional H-RS-like cells and the overlapping immunophenotype of the tumor ceUs.'78.'",22A-227.231 In practice, H-RS cells in HD are frequently CD15+, CD30', CD45-, EMA-, in contrast to ALCL tumor cells with CD15-, CD30+, CD45+, EMA+ immunophenotype.2322"1 HD is in 50% to 60% of cases associated with EBV. 63 The association of EBV with CD30' ALCLs remains controverbone. 178, [224] [225] [226] [227] [228] [229] [230] For personal use only. sial (range, 0% to 67% of cases positive), but most data would support the lack of a strong relationship between CD30' ALCLs and EBV."4-"7 These findings suggest that the presence of CD30 is not a simple relation to EBV infection in malignant lymphomas.
Several EBV-ALCL-derived cell lines show strong CD30 expression and could be biologic targets for CD30L. In contrast to the HD-derived cell lines, CD30 mediates reduction of proliferation and cell growth arrest (antiproliferative effect) for most of the CD30' ALCL cell lines."' The antiproliferative effect of CD30L includes a cytolytic effect and a cytostatic component with cell cycle arrest.'" The rnechanism for the cytolytic effect is presently unlear, but seems to be FAS-independent and not associated with apoptotic DNA fragmentation. Further investigations have to clarify the interaction between tumor growth of the CD30' anaplastic lymphoma cells, tumor progressionhegression. and CD30L expression in ALCL-involved tissues (Fig S) .
It is of interest, that the t:2;S translocation is a common chromosomal finding for CD30' ALCLS."'.'~"
This rearrangement fuses the nucleolar phosphoprotein nucleophosmin (NPM) gene on chromosome 5q3S to the novel tyrosine kinase gene ALK (anaplastic lymphoma kinase) on chromosome 2~23.'~' The association of the overexpression of the truncated ALK-fusion protein with the malignant transformation in the CD30' ALCLs is presently unclear, but an 80-kD protein tyrosine kinase (identical to ALK) has been suggested to physically interact with CD30.13' It is of interest that only a fraction of CD30' ALCL ( 1 2% to 40%) cases show the rearrangement of the NPM gene and that at least 
I
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From a fraction of HD cases may contain the NPWALK fusion transcripts (3 studies using reverse transcriptase-polymerase chain reaction [RT-PCR]: 0 of 40, 2 of 9, and 9 of 13 HD cases rearranged)."242 Further studies have to show whether HD cases with rearranged NPM gene represent ALCLs that mimic HD or whether it presents a separate HD subform closely related to ALCL. In addition, CD30f ALCLs present frequently with abnormal c-myc gene products (6 of 18 cases [33%]), but the functional significance of this is ~n c l e a r .~' Taken together, recently several molecular alterations for CD30+ ALCLs have been identified. Further studies will hopefully connect these molecular abnormalities with the functional role of CD30-CD30L interaction for oncogenesis and pathogenesis of ALCLs. In addition, the prognostic, biologic, and functional role of CD30 expression of the malignant cells of other NHLs needs further evaluation.
CD40L SHARES COMMON BIOLOGIC ACTIVITIES WITH CD3OL FOR HD
CD40 is a 50-kD glycoprotein and is expressed on a variety of cell types, including normal, virally transformed and malignant B cells (see below for more details), but also monocytes, activated T cells, follicular dentritic cells, interdigitating reticulum cells, thymic epithelium, and some epithelial carcinoma^.^^*^^'.^^^ Recently, the murine and human CD40L have been characterized and cloned?8" The CD4OL is a 33-to 39-kD type I1 membrane glycoprotein and is expressed primarily on the surface of activated CD4+ T cells but also on some CD8' T cells, mast and stromal cell '" Functional analysis of the CD40' cultured H-RS cells showed a 50% increase of colony formation using a soft agar system:57 but CD40L had no mitogenic activity on these CD40' HD-derived cell lines?5* Recombinant CD4OL induced IL-8 secretion and enhanced IL-6, TNF, and LTa from cultured H-RS cell lines?58 In addition, CD40L enhanced the expression of activation and adhesion molecules, such as ICA"1, B7-1, and B7-2, all of which are overexpressed on primary H-RS cells.L'7~258~26L-2" Furthermore, CD40L induced a 40% to 60% reduction of the expression of the HD-associated CD30 antigen with an increase of sCD30 levels. 258 Taken together, CD30L and CD40L share pleiotropic biologic activities on H-RS cells such as inductiodelevation of cytokine secretion and adhesiodactivation surface molecule expression (Table 5 and sion was preferrentially localized in the mantle zone and germinal center light zone of secondary follicles of all peripheral lymphoid tissues and also the T-cell-rich periarteriolar areas in the spleen.'" In vivo, CD40L-expressing cells are mainly CD4' T cells.'" A panel of T-cell NHLs and leukemias (87 cases) was investigated for localization of CD40L expression.'" Immunohistochemical staining showed that 21 of the 87 cases (24%) expressed CD40L with membrane and/or cytoplasmic immunoreactivity of a majority of neoplastic cells. In addition, the unexpected constitutive expression of CD40L by the neoplastic T cells was found mainly for CD4' tumors with a mature T-cell phenotype. The association of constitutive CD40L expression for some T-cell tumors with clinical and immunologic presentation such as hypergammaglobulinemia, monoclonal gammapathies, immune complex disease, or autoantibody syndromes needs to be established for the abnormal activation of B cells through malignant T cells. CD40L might provide a growth advantage for a subgroup of T-cell neoplasias.
An activation-induced growth arrest has been observed for several B-and T-cell malignancies through either antigen receptor or costimulatory receptors with antitumor effects when exposed to stimuli that lead to activation of the normal counterpart^."^^^^ It is of great interest that antiCD40 and soluble CD40 ligand significantly inhibited (40% to 60%) the in vitro proliferation of a series of B-cell lymphoma cell line^.'^^^''" In addition, an antitumor effect of anti-CD40 treatment was observed in SCID mice bearing the human Bcell lymphoma lines with increased survival and inhibition of tumor growth.'"' Furthermore, anti-CD40 MoAb prevents human B-cell lymphomagenesis in the hu PBL-SCID mouse, but also promotes human B-cell engraftment in vivo.'93 CD40L may be of significant clinical use in new treatment modalities of CD40' NHLs with or without conjugation to immunotoxins or radioisotopes.
Taken together, CD40 expression on malignant B cells seems to be a frequent finding and a potential candidate for alternative treatment approaches, such as tumor targeting (Fig 7) . Expression and the pathophysiologic role of CD40L for NHLs requires further functional analysis in vitro and in vivo (Fig 7) .
ROLE OF FAS/FASL SYSTEM FOR LYMPHOMAS
Cell survival and function is controlled by proliferation and differentiation (positive selection) but also by cell death (negative selection).'y4.'y5 The death of cells occurs by either programmed cell death with apoptosis or n e c r o s i~.~~~~'~' Apoptosis can be morphologically and biochemically distinguished from necrosis. In most cases, apoptosis is associated with condensation and segmentation of nuclei, loss of plasma membran microvilli, and degradation of chromosomal DNA into 200-bp nucleosome fragment^.'^'"^' FAS and APO-l antigens were identified by MoAbs with cytolytic activity against certain human cells and subsequently cDNA ~l o n " g .~'~'~~' '~~"~ FAS and APO-I antigen are identical molecules and have been assigned to cluster CD95.'X~1y~2y' The CD95 antigen acts as a cell-surface receptor that is involved in apoptosis, including T-and B-cell deletion for the immune s y~t e m ?~. '~~-'~~ In vivo, CD95 MoAbs induce rapid tumor r e g r e~s i o n . '~~. '~ CD95 expression is found on myeloid cells, fibroblasts, and activated lymphocytes, as well as on various lymphoma and leukemia cells, but is not always associated with cell cells transformed with HTLV-l and -2, HIV, or EBV also highly express functional CD95 antigen.3""3N CD95 is also expressed in tissues such as liver, heart, lung, and ovary.'9' Detailed analyses have shown that the CD95 antigen is weakly expressed on the surface of most malignant B cells isolated from CLLs, but is upregulated by stimulation with 
In addition, lymphoblastoid
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Staphylococcus aureus Cowan I (SAC) or IL-2 and showed CD95-mediated a p o p t o~i s .~~~
In contrast, HCL B cells expressed CD95 at moderate levels.305 The induction of CD95-mediated apoptosis was correlated in some instances with bcl-2 downreg~lation.~~~ The bcl-2 expression is correlated with inhibition of apoptosis3" and deregulation of bcl-2 expression might be part of the pathogenesis of lymphomas (eg, follicular lymphomas) and leukemias (eg, B-cell CLL).307 In addition, mediastinal B-cell lymphomas coexpress, depending on their differentiation stage, CD95 and CD54. 308 Interestingly, B cells from one CLL cases did not show bcl-2 downregulation after stimulation with SAC and IL-2, and
CD95 MoAb induced a proliferative
Further, one case of B-cell lymphoma stimulated with IL-14 also showed significant growth enhancement with CD95 MoAb treatment.3w Similarly, fresh PBTs showed a costimulatory response in the presence of CD95 MoAbs or sCD95L, but chronic activated PBTs or T-cell clones underwent CD95 expression of Burkitt's lymphoma (BL) cell lines is associated with a lymphoblastoid p h e n~t y p e .~~ EBV-and EBV+ BL cell lines with type I phenotype (CD10+, CD21-, CD23-, CD30-, CD39-, CD70-, CD777 corresponding to primary BL tumor cells have no detectable CD95 surface expression. Accordingly, primary BL tumor cells (3 cases) were also CD95-. In contrast, EBV+ BL cell lines with type I11 lymphoblastoid phenotype (CD10-, CD21+, CD23+, CD30+, CD39+, CD70+, CD77-) as well as normal lymphoblastoid B-cell lines expressed the CD95 antigen at high density, but 6 of 7 CD95+ BL cell lines were not sensitive to CD95-mediated killing. In addition, only one of eight Bcell NHLs and one of two T-cell NHLs expressed low levels of CD95, which was upregulated by IL-14.3w The expression of the CD95 antigen has been reported for the malignant cells of 83% (10 of 12 patients) of follicular lymphoma cases and 56% (18 of 32 patients) of diffuse lymphoma cases.313
Subgrouping into different histiologic subgroups showed similar distribution for all
In addition, all adult T-cell leukemia cases (n = 12) were CD95+ and underwent apoptosis by adding CD95 M o A~s .~'~ The detailed functional role of CD95 for cell survival and tumor growth is presently not well understood. Recently, the cognate for CD95 (CD95LZASL) has been cloned and characterized as a 31-kD type I1 transmembrane protein with 25% to 30% homology to other members of the TNF ligand ~uperfamily.~~ Recombinant CD95L exists also in a soluble form, with similar biologic activities seen for the CD95 MoAbs or membranebound CD95L.4' The physiologic presence and role of the sCD95L remain to be determined.
CD95 and CD95L expression and function has not been well investigated for HD, but the HD-derived cell lines HDLM-2, K"H2, L-428, and L-540 express CD95 and show apoptosis after treatment with CD95 MoAbs or soluble CD95L (H.J.G., manuscript in preparation).
In general, CD95 shares a dual role with the ability to mediate stimulatory or inhibitory/cytotoxic signals depending on the target cells or activation stage. The CD%/ CD95L-mediated T-cell cytotoxicity could play a major role in controlling the immune response of peripheral lympho-
~~ptoS~S~123,128,3M).302,310~312
cytes and might be involved in T-cell t~l e r a n c e .~~~.~'~ In general, the cloning of the CD95L will further improve our understanding of the mechanisms of apoptosis and the functional relevance of CD95(FAS)-CDML(FASL) interaction for malignancies, particular lymphoid tumors, such as a variety of lymphomas and leukemias with B-and T-cell phenotype.
4-1BW4-IBBL INTERACTION AND THE PATHOGENESIS OF LYMPHOMAS
4-1BB was identified and cloned from activated T cells (activation induced cDNA clone).10~16~"~317*318 The 33-kD 4-1BB molecule is expressed on activated T cells (CD4+ and CD8') and t h y m o~y t e s .~~,~' ' .~~~ 4-1BB antibodies have costimulatory activity for T-cell pr~liferation.~'~ Initially, it was reported that extracellular matrix proteins bind 4-1BB, but the functional relevance remains unclear.320 Subsequently, murine and human 4-1BB ligands were identified and expression c l 0 n e d . 4~~~ Expression of 4-IBBL was found for activated T cells, stromal cells, activated macrophages, EBV-transformed B cells, some tumor and leukemia cell lines, and a variety of tissues such as brain, placenta, lung, skeletal muscle, and l~i d n e y .~~, " ,~ 4-IBBL costimulates Tcell and thymocyte proliferation, but other biologic activities for the immune system and hematopoesis that are indicated by the wide distribution pattern of 4-1BB and 4-IBBL need to be identified. It is of additional interest that signals through 4-1BB enhance activation-induced cell death (AICD) of T cells." 4-IBBL is able to function as a signal transducing molecule.84 4-1BB and 4-1BBL are expressed on activated T cells and could play an autocrine regulatory role in T-cell intera~tion."".~ Primary lymphomas have not been analyzed for 4-1BB and 4-IBBL expression, but a series of HDderived cell lines express, in addition to the TNFRs, CD30, CD40, and FAS also 4-1BB (H.J.G., manuscript in preparation). The functional and pathologic relevance needs to be examined.
THE OX40 MOLECULE AND HD
The OX40 molecule was originally described as a cell surface antigen on activated rat T cells32'; subsequently, the genes encoding rat, mouse, and human OX40 have been to be restricted to activated CD4+ T ce11s.322.323 The human OX40 molecule is identical to the ACT35 antigen, described as strictly activation-associated antigen.162.324 No expression was found for resting peripheral blood lymphocytes, peripheral blood B cells, and thymocytes. In lymphoid tissue, huOX40 expression was seen for scattered cells in the interfollicular zone, the follicular mantle zone, and the germinal centers.16' Tissue macrophages were more weakly positive. For HD, only a few cases showed OX40 expression of H-RS cells, but T cells surrounding H-RS cells in a rosette fashion were strongly positive. 162 Recently, murine and human OX40L have been cloned from the murine lymphoma cell line S49.1 or the activated B-lymphoblastoid cell line MSAB, respectively, and the human homoloque identified to be gp34, a protein expressed on HTLV-1 -infected human
Cloned.45.46,322-324 Expression of OX40 was reported initially
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From leukemic T ce11s?5,46*325.326 OX40L expression is, as the OX40 receptor, selectively induced on activated CD4+ and CD8' T cells, but not on B ~ells.4~ The OX40L is also expressed on HTLV-1 -transformed cell lines, stimulated Blymphoblastoid cell lines, and THP-1 cells.& AS predicted, human OX4OL costimulates T-cell proliferation and cytokine production (eg, JL-2 and IL-4) as part of the regulatory cascade for immune r e s o n s e~.~~~~ A possible correlation between the OX4O/OX4OL system and virally induced pathogenesis needs further evaluation. Detailed expression and functional analyses have to be performed to understand the role of OX4O-OX4OL for the pathogenesis and/or tumorigenesis of lymphomas, particularly in the context of viral transformation (eg, EBV, HTLV, and HIV).
TNF AND LT EXPRESSION IN HD WITH UNCLEAR BIOLOGIC RELEVANCE
TNF was originally defined by its antitumor activity but is also a major mediator of inflammation and cellular immune response.8 TNF was found to be cytotoxic to a number of transformed cell lines in TNF induces cachexia in LPS-treated mice with profound effects on general cellular metabolism and development of weight loss, fever, acute phase reaction, infection, or neoplasia.328 TNF enhances the proliferation of T cells, modulates T-cell receptor expression, enhances NK cell activity, and regulates human B-cell function. TNF also has marked effects on neutrophils, eosinophil recruitment, monocyte/macrophage activation, fibroblast growth stimulation, and endothelial celllleukocyte interact i o n~.~~~ TNF is produced by many cell types, including monocytes/macrophages, lymphocytes, and fibroblasts.' Activated macrophages have the highest TNF prod~ction.'~'
LT is a cytokine structurally related to TNF with approximately 50% sequence homology, the same chromosomal localization, and trimer structure.8 LT is synthesized primarily by T cells, although some EBV-transformed B-cell lines and tonsil B cells produce it.8 LT and TNF have similar but not identical inflammatory and immunomodulatory activities8 LT is often less potent than TNF. Initially, LT (TNF-P) was cloned as a soluble ~y t o k i n e .~~~ Surface LT does not result from the presence of the transmembrane region but, rather, was found associated with a 33-kD integral membrane glycopr0tein.7~1~~ The cloned gene encoding this second protein in the surface LT complex was found to be a new member of the TNF ligand ~uperfamily.~~ Recently, the LT complex units have been renamed as LTa (TNF-PLT) and LT0 (p33), being synthesized in soluble form as a LTa homotrimer or as a membrane-anchored heterotrimeric complex composed of LTa and LTP units (eg, P2a1).35 Generic ligand-receptor interaction analysis predicts that the heterotrimeric LT0 complex would produce a functionally inactive receptor-binding ~r o t e i n .~~.~~ The immunologic function and biologic role of LTP is presently not well understood.
Receptors for TNF and LT are expressed at low levels on most tissues and various cell type^. In comparison with TNF, the LTa-specific mRNA signals were usually of higher intensity and present in larger proportions of H-RS cells.175 TNF and LTa gene transcripts were also seen in some lymphoid cells.
Most HD-derived cell lines express the p60 and p80 TNFRs on their surface or at the mRNA The presence of TNFR-RP protein on cultured or primary H-RS cells has not been investigated. Limited data are available for the TNFR expression in HD cases. One study reported the expression of p60 TNFR in 1 of 4 (25%) and p80 TNFR in 2 of 4 (50%) HD cases analyzed using immunohistochemi~t r y .~~' Further detailed expression studies for primary HD material are required to fully understand the involvement of TNF and LTa for the pathogenesis of HD, including growth control for H-RS cells. These different studies indicate that TNF and LTa expression of the malignant H-RS cells in HD-involved tissue is a frequent finding and could have a central functional relevance for oncogenesis and pathogenesis of HD (Fig 8) . Highlevel expression of LTa for cultured and primary H-RS cells is a striking feature for HD, with unknown biologic correlation.M Primary and cultured H-RS cells express not only TNF and LTa but also the TNFRs, suggesting a possible autocrine growth loop for H-RS cells (Fig 8) . TNF and LTa lack mitogenic activity on cultured H-RS cells and a presumed autocrine growth loop, based on coexpression of corresponding ligands and receptors, has so far not been shown. 
B. LT-a
S t r S a m -
might interact with surrounding bystander cells, particularly T cells; conversely, H-RS cells might respond to cytokines produced by surrounding normal reactive bystander cells. TNF and LTa are part of these deregulated cytokine network involved in HD. TNF and LTa could be involved in causing fever, weight loss, and night sweats, as cytokines involved in the development of the constitutional B symptoms.'28 TNF is also mitogenic for fibroblasts and induces collagen synthesis with a potential role in formation of sclero~is.~'' Elevation of, eg, fibrinogen or prostaglandin serum levels, frequently seen in HD, could be associated with TNF se~retion.~~.'~' It is of interest that HD patients have elevated TNF serum levels (47 of 76 HD patients [62%]); the extent of increase correlated with disease stage and the presence or absence of B symptoms.'" Similarly, the mean serum levels of the soluble p60 TNFR were significantly higher in HD patients than in healthy
The degree of increase correlated with TNF serum levels, disease stage, and disease activity (presence of B symptoms). Furthermore, increased soluble p60 TNFR serum levels of HD patients in remission could be involved in the cellular immune defect characteristic for HD might support the escape of H-RS cells in the predisposing immunocompromised host from the tumor-suppressive effects of TNF and LTa and also cellular antitumor immune response by blocking appropriate T-cell activation and function. In addition, systemic TNF might be causative with other immune modulators, such as IL-1 and IL-6, in development of B symptoms and/or metabolic wasting (Fig 8). patients."s.34" The elevated soluble TNFR concentration
TNF AND TNFR INTERACTION FOR NHLS
Immunohistochemical studies of nonmalignant, reactive cells showed that TNF-positive cells were rarely detected in lymph nodes with activation of the B-cell compartment but were frequently detected in sections from patients with dif- showed weak scattered TNF-positive cells.'"' In the four Tcell NHLs, TNF was not detectable on the neoplastic lymphoma cells but was detectable on macrophages in Tcell paracortical areas.2h5 In contrast to the high frequency of TNF and, particularly, the LTa expression of the neoplastic H-RS cells in HD, the neoplastic lymphoma cells of NHLs seems only rarely to produce TNF and LTa as an indicator of their malignant transformation. Similarly, RNA prepared from nonmalignant. reactive lymph nodes confirmed low expression of TNF and LTa..'" In contrast, moderate to abundant levels of TNF mRNA were detected in 12 of 35 NHL specimens (33% of cases positive; 9 low-grade and 3 high-grade NHLs).'~' In contrast, in situ hybridization with IL-6, TNF, and LTa probes of eight lymphoplasmacytic lymphomas lacked IL-6, TNF, and LTa expre~sion."~ Variable amounts of increased LTa mRNA were detected in 19 of 35 NHL specimens (54% of cases positive).'" Ten of the NHL cases coexpressed TNF and LTa mRNA?' Interestingly, 8 of 12 lymphoma patients (67% of cases) with the presence of systemic B symptoms had high TNF mRNA levels and 11 of these 12 lymphoma cases (92% of cases) had also abundant LTa mRNA expression."' High TNF and LTa mRNA expression correlated significantly with the presence of systemic B symptoms. Similarly, murine and human NHL cell lines express either constitutively TNF and LTa mRNA and protein or can be Further detailed studies are needed to confirm these initial results and to demonstrate the localization of TNFLTa-expressing cells.
So far, only one study analyzed p60 and p80 TNFR expression systematically by using immunohistochemistry for normal tissues and NHL specimens.."' For the normal dependent areas 265.347. 348 .. 
As presumed, strong TNF signals
SUMMARY
The TNF receptor superfamily members are all type I membrane glycoproteins with typical homology in the extracellular domain of variable numbers of cysteine-rich repeats (overall homologies, 25% to 30%). In contrast, the TNF ligand superfamily members (with the exception of LTa) are type I1 membrane glycoproteins with homology to TNF in the extracellular domain (overall homologies, 20%). TNF and LTa are trimeric proteins and are composed of P-strands forming a P-jellyroll. The homology of the &strand regions for the TNF ligand superfamily members suggest a similar ,&sandwich structure and possible trimeric or multimeric complex formation for most or all members. A genetic linkage, as evidence for evolutionary relatedness, is found by chromosomal cluster of TNFR p80, CD30, 4-1BB, and OX40 for lp36; TNFR p60, TNFR-RP, and CD27 for 1 2~1 3 ; TNF, LTa, and LTP for 6 (MHC locus); CD27L and 4-lBBL for 1 9~1 3 ;
and FASL and OX40L for lq25. Of the TNF ligand superfamily, TNF, LTa, and LTP and their receptors (TNFR p60, TNFR p80, and TNFR-RP) interact in a complex fashion of cross-binding. However, the other family members presently have a one ligandone receptor binding principle (CD27/CD27L, CD30/CD30L, CD40/ CD40L, 4-1BB/4-1BBL, OX4O/gp34, and FASIFASL). In general, the members of the TNF ligand superfamily mediate interaction between different hematopoietic cells, such as T cell/B cell, T cell/monocyte, and T c e l n cell. Signals can be transduced not only through the receptors but also through at least some of the ligands. The transduced signals can be stimulatory or inhibitory depending on the target cell or the activation state. Taken together, TNF superfamily ligands show for the immune response an involvement in the induction of cytokine secretion and the upregulation of adhesion molecules, activation antigens, and costimulatory proteins, all known to amplify stimulatory and regulatory signals. On the other hand, differences in the distribution, kinetics of induction, and requirements for induction support a defined role for each of the ligands for T-cell-mediated immune responses. The shedding of members of the TNF receptor superfamily could limit the signals mediated by the corresponding ligands as a functional regulatory mechanism. Induction of cytotoxic cell death, observed for TNF, LTa, CD30L, CD95L, and 4-1BBL, is another common functional feature of this cytokine family. Further studies have to identify unique versus redundant biologic and physiologic functions for each of the TNF superfamily ligands.
Primary H-RS cells can express TNF, LTa, and CD27L but not CD30L and CD40L, in addition to IL-la, IL-5, IL-6, IL-9, and M-CSF. The functional role of cytokines for the pathogenesis of NHLs is presently unclear. Malignant NHL cells express, depending on their immunophenotype, several TNF receptor and ligand superfamily members. B-cell NHLs are frequently CD27/CD27L, CD30 or CD30L. CD40, and TNFRs/ TNF positive, but T-cell NHLs have expression of CD30, CD40L, and TNFRs/TNF. Further functional analysis will increase our understanding of the involvement of TNF superfamily ligands in the pathogenesis of NHLs.
Several TNFR superfamily members could be candidates for novel treatment protocols. Recombinant CD30L and CD40L could be by itself antitumorigenic for CD30 148. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314, 1992 For personal use only. on July 15, 2017. by guest www.bloodjournal.org 
